High Quality Fudosteine CAS 13189-98-5 Powder Fast Shipping Better Price

Fudosteine More Info

Introduction
Fudosteine is an orally active mucolytic agent and a synthetic derivative of L-cysteine, a naturally occurring amino acid. It is a key pharmaceutical raw material widely used in the clinical management of respiratory tract diseases characterized by excessive and viscous mucus secretion. Unlike some traditional mucolytics that only act on mucus viscosity, fudosteine exerts a multi-targeted effect on the respiratory tract, making it effective for both acute and chronic respiratory conditions with sputum-related symptoms. Its chemical formula is C₆H₁₁NO₄S, and it is formulated into oral preparations such as tablets, capsules, and granules for clinical use, with good oral bioavailability and tolerability.
Core Pharmacological Mechanism (to support its therapeutic uses)
Fudosteine exerts its mucolytic and respiratory protective effects through three main mechanisms: first, it inhibits the overproduction of mucin (the main component of sputum) in airway epithelial cells, reducing the synthesis of viscous respiratory mucus at the source; second, it breaks the disulfide bonds in mucin molecules, directly lowering the viscosity and elasticity of sputum, making it easier to cough up and expel; third, it protects the airway epithelial barrier, inhibits airway inflammatory responses, and improves the mucociliary clearance function of the respiratory tract—this unique protective effect differentiates it from single-action mucolytics and helps reduce the recurrence of respiratory symptoms.
Primary Therapeutic Uses
Fudosteine is clinically indicated as a first-line symptomatic treatment for a variety of acute and chronic respiratory diseases associated with excessive viscous sputum, difficult expectoration, and airway mucus hypersecretion. Its specific clinical applications are as follows:
Chronic Obstructive Pulmonary Disease (COPD)It is a core adjuvant drug for both stable and acute exacerbation phases of COPD, including chronic bronchitis and pulmonary emphysema. For COPD patients, fudosteine effectively relieves persistent cough and sticky sputum symptoms, reduces the frequency of acute exacerbations caused by sputum obstruction, and improves lung ventilation function and exercise tolerance when combined with bronchodilators or anti-infective drugs.
Bronchial AsthmaIt is used as an adjuvant treatment for asthma patients (especially those with persistent asthma or asthma complicated by mucus hypersecretion). Asthma attacks are often accompanied by increased airway mucus and viscous sputum, which can aggravate airway obstruction; fudosteine relieves this obstruction by reducing sputum viscosity and promoting expectoration, and its anti-inflammatory effect on the airway also helps reduce the severity of asthma symptoms and improve the efficacy of asthma control drugs such as inhaled corticosteroids.
Chronic Bronchitis (acute and stable phases)For acute exacerbations of chronic bronchitis caused by bacterial/viral infections, fudosteine is combined with anti-infective drugs to quickly relieve cough and difficult expectoration, shorten the course of the acute phase; for stable chronic bronchitis patients, long-term low-dose maintenance use can reduce the frequency of symptom recurrence and improve the quality of life.
BronchiectasisIt is a key symptomatic drug for patients with bronchiectasis, who often suffer from persistent purulent sputum and recurrent respiratory infections due to structural damage of the bronchus and impaired mucociliary clearance. Fudosteine promotes the discharge of purulent and viscous sputum, reduces sputum retention in the bronchus, and thereby lowers the risk of secondary bacterial infections and the progression of bronchiectasis.
Adjuvant treatment for other respiratory diseasesIt is also used for symptomatic relief of sputum-related symptoms in the recovery phase of community-acquired pneumonia/hospital-acquired pneumonia (after anti-infective treatment, residual sticky sputum), as well as in occupational lung diseases (e.g., pneumoconiosis) and interstitial lung diseases with secondary mucus hypersecretion. In pediatric clinical practice, it is also used for acute bronchitis and bronchiolitis in children (dose adjusted by body weight) to relieve cough and difficult expectoration in children who cannot effectively cough up sputum.

Product Image

FAQ

Q1. Can I get a free sample?

We can send you a samll free sample, and you only need to pay for the shipping cost.

Q2. What is the HyperChem payment term?

T/T in advance
LC at sight
DP at sight

Bank transfer

PayPal

Bitcoin...

Q3. What is HyperChem shipment policy?

Our policy is to strive for the quickest shipment time possible.

For ready stock samples, they are usually shipped within 3 working days after payment received.
For non-ready stock, please contact HyperChem sales team to negotiate.

Q4. What is HyperChem shipment term?

By Express  
FedEx  UPS  DHL  EMS                               
Fast: 3-7 days around, high cost, door to door service

By Air                                        
Suitable for more than 50kg 
Fast: 3-7 days, hight cost, port to port, professional broker needed 

By Sea
Suitable for more than 500kg      
Fast: 7-45 days, low cost, port to port, professional broker needed 

We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.

Q5. What HyperChem will provide after shipment?

For sample orders: 
After shipment is done, an timely email including:

1. Track details (Fedex /TNT/DHL/EMS Track number)
2. Packaging photo
3. COA, MSDS, etc
4. Dispatch date & Estimated arriving time
5. Shipping invoice

For commercial orders:
A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.